Prevalence of cognitive impairment in liver transplant recipients.
Alzheimer's
cirrhosis
cognitive decline
dementia
organ transplant
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
19 Dec 2023
19 Dec 2023
Historique:
revised:
06
11
2023
received:
30
08
2023
accepted:
10
12
2023
medline:
19
12
2023
pubmed:
19
12
2023
entrez:
19
12
2023
Statut:
aheadofprint
Résumé
Liver transplant (LT) recipients have a high burden of cognitive impairment risk factors identified in other populations, yet little work has explored cognition in the United States LT population. We characterized prevalence of cognitive impairment (CI) in LT recipients pre-LT and ≥3 months post-LT. Adult LT recipients with cirrhosis but without active pre-LT hepatic encephalopathy (HE) were screened for CI using the Montreal Cognitive Assessment (MoCA) for CI (MoCA <24) both pre-LT and ≥3 months post-LT. The association between cognitive performance and recipient characteristics was assessed using logistic regression. Of 107 LT recipients, 36% had pre-LT CI and 27% had post-LT CI [median (Q1-Q3) MoCA 26 (23-28)]. Each 1-point increase in pre-LT MoCA was associated with 26% lower odds of post-LT cognitive impairment (aOR .74, 95% CI .63-.87, p < .001), after adjusting for recipient age, history of HE, and time since LT. In this study of cirrhosis recipients without active pre-LT HE, cognitive impairment was prevalent before LT and remained prevalent ≥3 months after LT (27%), long after effects of portal hypertension on cognition would be expected to have resolved. Our data expose an urgent need for more comprehensive neurologic examination of LT recipients to better identify, characterize, and address predictors of post-LT cognitive impairment.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15229Subventions
Organisme : NIA NIH HHS
Pays : United States
Informations de copyright
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic steatohepatitis: a review. Jama. 2020;323(12):1175-1183.
Thoefner LB, Rostved AA, Pommergaard HC, Rasmussen A. Risk factors for metabolic syndrome after liver transplantation: a systematic review and meta-analysis. Transplant Rev (Orlando, Fla). 2018;32(1):69-77.
Ruck JM, King EA, Chu NM, Segev DL, McAdams-DeMarco M. Cognitive dysfunction in liver disease and its implications for transplant candidates. Curr Transplant Rep. 2023;10(1):21-27.
Albhaisi SAM, Bajaj JS. Cognitive function in liver transplantation. Curr Transplant Rep. 2020;7(2):31-37.
Wijdicks EF. Hepatic encephalopathy. N Engl J Med. 2016;375(17):1660-1670.
Aceto P, Perilli V, Lai C, Ciocchetti P, Vitale F, Sollazzi L. Postoperative cognitive dysfunction after liver transplantation. Gen Hosp Psychiatry. 2015;37(2):109-115.
Fineberg SK, West A, Na PJ, et al. Utility of pretransplant psychological measures to predict posttransplant outcomes in liver transplant patients: a systematic review. Gen Hosp Psychiatry. 2016;40:4-11.
Hopp AE, Dirks M, Petrusch C, et al. Hepatic encephalopathy is reversible in the long term after liver transplantation. Liver Transpl. 2019;25(11):1661-1672.
Pflugrad H, Schrader AK, Tryc AB, et al. Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation. Liver Transpl. 2018;24(1):56-66.
Ko D, Bratzke LC. Cognitive function in liver transplant recipients who survived more than 6 months. Prog Transplant. 2020;30(4):335-341.
Lai JC, Covinsky KE, Dodge JL, et al. Development of a novel frailty index to predict mortality in patients with end-stage liver disease. Hepatology. 2017;66(2):564-574.
Weissenborn K, Ennen JC, Schomerus H, Rückert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34(5):768-773.
Weissenborn K, Rückert N, Hecker H, Manns MP. The number connection tests A and B: interindividual variability and use for the assessment of early hepatic encephalopathy. J Hepatol. 1998;28(4):646-653.
Rossetti HC, Lacritz LH, Cullum CM, Weiner MF. Normative data for the Montreal Cognitive Assessment (MoCA) in a population-based sample. Neurology. 2011;77(13):1272-1275.
Nasreddine ZS, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53(4):695-699.
Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165(6):710-718.
Lewis MB, Howdle PD. Cognitive dysfunction and health-related quality of life in long-term liver transplant survivors. Liver Transpl. 2003;9(11):1145-1148.
Berry K, Duarte-Rojo A, Grab JD, et al. Cognitive impairment and physical frailty in patients with cirrhosis. Hepatol Commun. 2022;6(1):237-246.
Berry K, Asken BM, Grab JD, et al. Hepatic and renal function impact concentrations of plasma biomarkers of neuropathology. Alzheimers Dement. 2022;14(1):e12321.
Berry K, Copeland T, Ku E, Lai JC. Perioperative delta sodium and post-liver transplant neurological complications in liver transplant recipients. Transplantation. 2022;106(8):1609-1614.
Berry K, Rubin JB, Lai JC. Osmotic Demyelination syndrome in hospitalized patients with cirrhosis: analysis of the National Inpatient Sample (NIS). J Clin Gastroenterol. 2022;56(3):280-283.
Lescot T, Karvellas CJ, Chaudhury P, et al. Postoperative delirium in the intensive care unit predicts worse outcomes in liver transplant recipients. Can J Gastroenterol. 2013;27(4):207-212.